Skip to main content
Journal ArticleOPEN ACCESS

Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study

  • Levine M
  • Pearlman R
  • et al.
JCO Precision Oncology (2021) (5) 1588-1602
DOI: 10.1200/po.21.00249
18Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

PURPOSEClinical utility of up-front multigene panel testing (MGPT) is directly related to the frequency of pathogenic variants (PVs) in the population screened and how genetic findings can be used ...

Cite

CITATION STYLE

APA

Levine, M. D., Pearlman, R., Hampel, H., Cosgrove, C., Cohn, D., … Goodfellow, P. J. (2021). Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study. JCO Precision Oncology, (5), 1588–1602. https://doi.org/10.1200/po.21.00249

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free